Hybridize Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Hybridize Therapeutics General Information
Description
Developer of RNA-based therapeutics designed to treat acute and chronic kidney diseases. The company offers kidney-targeted RNA therapies, antisense oligonucleotide treatments, and RNA-based drug development programs for kidney disease and virus-related kidney disorders, enabling medical companies to develop targeted treatments with high specificity for renal conditions.
Contact Information
Website
www.hybridizetherapeutics.comCorporate Office
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
Corporate Office
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
Hybridize Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 01-Apr-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2018 | Completed | Startup |
Hybridize Therapeutics Signals
Hybridize Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mibiton | Venture Capital | Minority | ||
| Termeer Institute | Accelerator/Incubator |
Hybridize Therapeutics FAQs
-
When was Hybridize Therapeutics founded?
Hybridize Therapeutics was founded in 2018.
-
Where is Hybridize Therapeutics headquartered?
Hybridize Therapeutics is headquartered in Oegstgeest, Netherlands.
-
What is the size of Hybridize Therapeutics?
Hybridize Therapeutics has 4 total employees.
-
What industry is Hybridize Therapeutics in?
Hybridize Therapeutics’s primary industry is Drug Discovery.
-
Is Hybridize Therapeutics a private or public company?
Hybridize Therapeutics is a Private company.
-
What is Hybridize Therapeutics’s current revenue?
The current revenue for Hybridize Therapeutics is .
-
Who are Hybridize Therapeutics’s investors?
Mibiton and Termeer Institute have invested in Hybridize Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process